T
Tim R H Read
Researcher at Monash University
Publications - 89
Citations - 2741
Tim R H Read is an academic researcher from Monash University. The author has contributed to research in topics: Men who have sex with men & Mycoplasma genitalium. The author has an hindex of 24, co-authored 88 publications receiving 2233 citations. Previous affiliations of Tim R H Read include Alfred Hospital & Royal Melbourne Hospital.
Papers
More filters
Journal ArticleDOI
Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial
Alan R. Lifson,Jacqueline Neuhaus,Jose R. Arribas,Mary van den Berg-Wolf,Ann M. Labriola,Tim R H Read +5 more
TL;DR: Smoking contributes to substantial morbidity and mortality in this HIV-infected population and providers should routinely integrate smoking cessation programs into HIV health care.
Journal ArticleDOI
Etiologies of Nongonococcal Urethritis: Bacteria, Viruses, and the Association with Orogenital Exposure
Catriona S. Bradshaw,Sepehr N. Tabrizi,Sepehr N. Tabrizi,Tim R H Read,Suzanne M. Garland,Suzanne M. Garland,Carol A Hopkins,Lorna M. Moss,Christopher K Fairley +8 more
TL;DR: Adenoviruses and HSV-1 were identified as significant causes of NGU with distinct clinical and behavioral characteristics and the association between insertive oral sex and NGU was highlighted.
Journal ArticleDOI
Azithromycin Failure in Mycoplasma genitalium Urethritis
Catriona S. Bradshaw,Jørgen Skov Jensen,Sepehr N. Tabrizi,Tim R H Read,Suzanne M. Garland,Carol A Hopkins,Lorna M. Moss,Christopher K Fairley +7 more
TL;DR: In vitro evidence supported reduced susceptibility of M. genitalium to macrolides and moxifloxacin administration resulted in rapid symptom resolution and eradication of infection in all cases, having implications for management of urethritis.
Journal ArticleDOI
Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.
Rebekah Puls,Janaki Amin,Marcelo H. Losso,Praphan Phanuphak,Chidi Nwizu,Catherine Orrell,Barnaby Edward Young,Eduardo Shahar,Marcelo Wolff,Brian Gazzard,Tim R H Read,Andrew F. Hill,David A. Cooper,Sean Emery +13 more
TL;DR: It is suggested that a reduced dose of 400 mg efavirenz is non-inferior to the standard dose of 600 mg, when combined with tenofovir and emtricitabine during 48 weeks in ART-naive adults with HIV-1 infection.
Journal ArticleDOI
Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation
Tim R H Read,Christopher K Fairley,Gerald L. Murray,Jørgen Skov Jensen,Jennifer Danielewski,Karen Worthington,Michelle Doyle,Elisa Mokany,Litty Tan,Eric P F Chow,Suzanne M. Garland,Catriona S. Bradshaw +11 more
TL;DR: Treating Mycoplasma genitalium with a sequence of first doxycycline to reduce bacterial load, and then using a resistance assay to choose either high-dose azithromycin or sitafloxacin, cured >92% of infections in a population with high levels of antibiotic resistance.